Binding of rituximab, trastuzumab, cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1 cells and monocytes. [electronic resource]
Producer: 20081229Description: 8120-32 p. digitalISSN:- 1550-6606
- Animals
- Antibodies, Monoclonal -- immunology
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal, Murine-Derived
- Antigen-Antibody Complex -- immunology
- Antigens, CD20 -- immunology
- Antigens, Neoplasm -- immunology
- Antirheumatic Agents -- immunology
- B-Lymphocytes -- immunology
- Cell Line, Tumor
- Cetuximab
- Humans
- Mice
- Monocytes
- Neoplasms -- drug therapy
- Receptors, IgG -- immunology
- Rituximab
- Trastuzumab
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.